Autologous human cardiac stem cells transplantation for the treatment of ischaemic cardiomyopathy: first study of human-induced pluripotent stem (iPS) cell-derived cardiomyocytes transplantation

Moriguchi, Hisashi; Madson, Joren
May 2013
BMJ Case Reports;May2013, p1
Academic Journal
No abstract available.


Related Articles

  • Distinct iPS Cells Show Different Cardiac Differentiation Efficiency. Ohno, Yohei; Yuasa, Shinsuke; Egashira, Toru; Seki, Tomohisa; Hashimoto, Hisayuki; Tohyama, Shugo; Saito, Yuki; Kunitomi, Akira; Shimoji, Kenichiro; Onizuka, Takeshi; Kageyama, Toshimi; Yae, Kojiro; Tanaka, Tomofumi; Kaneda, Ruri; Hattori, Fumiyuki; Murata, Mitsushige; Kimura, Kensuke; Fukuda, Keiichi // Stem Cells International;2013, p1 

    Patient-specific induced pluripotent stem (iPS) cells can be generated by introducing transcription factors that are highly expressed in embryonic stem (ES) cells into somatic cells. This opens up new possibilities for cell transplantation-based regenerativemedicine by overcoming the ethical...

  • CeeTox CDI work on new cardiac safety screening.  // Medical Device Daily;8/16/2012, Vol. 16 Issue 159, p4 

    The article introduces a new predictive cardiac safety screening service from CeeTox and Cellular Dynamics International that uses human induced pluripotent stem (iPS) cell-derived cardiomyocytes.

  • Monkeying around with cardiac progenitors: hope for the future. Li Qian; Srivastava, Deepak; Qian, Li // Journal of Clinical Investigation;Apr2010, Vol. 120 Issue 4, p1034 

    Multipotent cardiovascular progenitor cells derived from ES cells or induced pluripotent stem (iPS) cells are an intriguing source for stem cell-based therapies for congenital and acquired heart diseases. From a clinical perspective, the ideal cardiac progenitor cells are those that can...

  • iPS cells in humans. Cyranoski, David // Nature Biotechnology;Sep2013, Vol. 31 Issue 9, p775 

    The article discusses the clinical study regarding the induced pluripotent stem (iPS) cells in humans wherein it has the chance of success compared with other retinal pigment epithelium transplant.

  • Generation of male germ cells from induced pluripotent stem cells (iPS cells): an in vitro and in vivo study. Zhu, Yong; Hu, Hong-Liang; Li, Peng; Yang, Shi; Zhang, Wei; Ding, Hui; Tian, Ru-Hui; Ning, Ye; Zhang, Ling-Ling; Guo, Xi-Zhi; Shi, Zhan-Ping; Li, Zheng; He, Zuping // Asian Journal of Andrology;Jul2012, Vol. 14 Issue 4, p574 

    Recent studies have reported that induced pluripotent stem (iPS) cells from mice and humans can differentiate into primordial germ cells. However, whether iPS cells are capable of producing male germ cells is not known. The objective of this study was to investigate the differentiation potential...

  • Uses of cardiomyocytes generated from induced pluripotent stem cells. Tung-Ying Lu; Lei Yang // Stem Cell Research & Therapy;2011, Vol. 2 Issue 6, p1 

    Embryonic stem (ES) cells are naturally derived from early stage embryos and induced pluripotent stem (iPS) cells are reprogrammed from somatic cells with overexpression of four reprogramming factors, Oct4, Sox2, Klf4 and c-Myc. Both ES cells and iPS cells are pluripotent stem cells with...

  • Regenerative medicine opens new frontiers in treatment of AMD.  // Ocular Surgery News;7/10/2015, Vol. 33 Issue 13, p16 

    The article focuses on the message given by lecturer Masayo Takahashi at the 2015 European Society of Ophthalmology meeting concerning the autologous transplantation of induced pluripotent stem cells-retinal pigment epithelium (iPS-RPE) sheets.

  • Induction of Estrogen-Sensitive Epithelial Cells Derived from Human-Induced Pluripotent Stem Cells to Repair Ovarian Function in a Chemotherapy-Induced Mouse Model of Premature Ovarian Failure. Liu, Te; Qin, Wenxing; Huang, Yongyi; Zhao, Yanhui; Wang, Jiejun // DNA & Cell Biology;Dec2013, Vol. 32 Issue 12, p685 

    The incidence of premature ovarian failure (POF), a condition causing amenorrhea and hypergonadotropic hypoestrogenism in women before the age of 40, has been increasing in recent years. As an irreversible pathological change, improved treatment strategies for this disease are urgently needed....

  • Long-term Safety and Efficacy of Human-Induced Pluripotent Stem Cell (iPS) Grafts in a Preclinical Model of Retinitis Pigmentosa. Yao Li; Yi-Ting Tsai; Chun-Wei Hsu; Erol, Deniz; Jin Yang; Wen-Hsuan Wu; Davis, Richard J; Egli, Dieter; Tsang, Stephen H // Molecular Medicine;dec2012, Vol. 18 Issue 12, p1312 

    The U.S. Food and Drug Administration recently approved phase I/II clinical trials for embryonic stem (ES) cell–based retinal pigmented epithelium (RPE) transplantation, but this allograft transplantation requires lifelong immunosuppressive therapy. Autografts from patient-specific...

  • Generation of Induced Pluripotent Stem Cell Lines from Friedreich Ataxia Patients. Liu, Jun; Verma, Paul; Evans-Galea, Marguerite; Delatycki, Martin; Michalska, Anna; Leung, Jessie; Crombie, Duncan; Sarsero, Joseph; Williamson, Robert; Dottori, Mirella; Pébay, Alice // Stem Cell Reviews & Reports;Sep2011, Vol. 7 Issue 3, p703 

    Friedreich ataxia (FRDA) is an autosomal recessive disorder characterised by neurodegeneration and cardiomyopathy. It is caused by a trinucleotide (GAA) repeat expansion in the first intron of the FXN gene that results in reduced synthesis of FXN mRNA and its protein product, frataxin. We report...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics